467 related articles for article (PubMed ID: 10852454)
1. Endocrine consequences of long-term intrathecal administration of opioids.
Abs R; Verhelst J; Maeyaert J; Van Buyten JP; Opsomer F; Adriaensen H; Verlooy J; Van Havenbergh T; Smet M; Van Acker K
J Clin Endocrinol Metab; 2000 Jun; 85(6):2215-22. PubMed ID: 10852454
[TBL] [Abstract][Full Text] [Related]
2. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
[TBL] [Abstract][Full Text] [Related]
3. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain.
Daniell HW
J Pain; 2008 Jan; 9(1):28-36. PubMed ID: 17936076
[TBL] [Abstract][Full Text] [Related]
4. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels.
Lado-Abeal J; Rodriguez-Arnao J; Newell-Price JD; Perry LA; Grossman AB; Besser GM; Trainer PJ
J Clin Endocrinol Metab; 1998 Sep; 83(9):3083-8. PubMed ID: 9745407
[TBL] [Abstract][Full Text] [Related]
5. Androgen deficiency in long-term intrathecal opioid administration.
Kim CH; Garcia R; Stover J; Ritchie K; Whealton T; Ata MA
Pain Physician; 2014; 17(4):E543-8. PubMed ID: 25054405
[TBL] [Abstract][Full Text] [Related]
6. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
Laughlin GA; Dominguez CE; Yen SS
J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
[TBL] [Abstract][Full Text] [Related]
7. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD
J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
[TBL] [Abstract][Full Text] [Related]
8. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
9. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
10. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
11. Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer's dementia.
Tsolaki M; Grammaticos P; Karanasou C; Balaris V; Kapoukranidou D; Kalpidis I; Petsanis K; Dedousi E
Hell J Nucl Med; 2005; 8(1):39-42. PubMed ID: 15886752
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
13. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
14. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
15. Chronic spinal and oral morphine-induced neuroendocrine and metabolic changes in noncancer pain patients.
Valverde-Filho J; da Cunha Neto MB; Fonoff ET; Meirelles Ede S; Teixeira MJ
Pain Med; 2015 Apr; 16(4):715-25. PubMed ID: 25521923
[TBL] [Abstract][Full Text] [Related]
16. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
18. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
19. Hypogonadism in patients treated with intrathecal morphine.
Finch PM; Roberts LJ; Price L; Hadlow NC; Pullan PT
Clin J Pain; 2000 Sep; 16(3):251-4. PubMed ID: 11014399
[TBL] [Abstract][Full Text] [Related]
20. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]